TMCnet News
World Smoothened Homolog (Protein Gx or SMO) Pipeline Review 2016 - Research and MarketsResearch and Markets has announced the addition of the "Smoothened Homolog (Protein Gx or SMO) - Pipeline Review, H1 2016" report to their offering. The report 'Smoothened Homolog - Pipeline Review, H1 2016' outlays comprehensive information on the Smoothened Homolog (Protein Gx or SMO) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type; that are being developed by Companies / Universities. 'Smoothened Homolog - Pipeline Review, H1 2016'; Smoothened Homolog (Protein Gx or SMO) pipeline Target (News - Alert) constitutes close to 12 molecules. Out of which approximately 10 molecules are developed by Companies and remaining by the Universities/Institutes. Furthermore, the author says; Smoothened Homolog (Protein Gx or SMO) Smoothened homolog (SMO) is a G protein-coupled receptor that probably associates with the patched protein (PTCH) to transduce the hedgehog's proteins signal. Binding of sonic hedgehog (SHH) to its receptor is thought to prevent normal inhibition by patched of smoothened (SMO). It is required for the accumulation of KIF7 and GLI3 in the cilia.
Key Topics Covered:
For more information about this report visit http://www.researchandmarkets.com/research/29r5xk/smoothened Related Topics: Oncology Drugs
View source version on businesswire.com: http://www.businesswire.com/news/home/20160829005804/en/ |